Uganda extends Ebola lockdown in two hotspots
KAMPALA - Uganda’s president extended a sixweek lockdown Saturday on two districts at the epicentre of an an Ebola outbreak that has claimed 55 lives, but said its spread was being curbed.
Since the outbreak was declared on 20 September, Ebola has spread across Uganda and reached the capital Kampala, though health authorities this week said case numbers were falling.
The two central districts at the heart of the outbreak, Mubende and Kassanda, were placed under a 21-day lockdown by President Yoweri Museveni on 15 October.
The measures including a dusk-to-dawn curfew, a ban on personal travel, and the closure of markets, bars and churches were extended on 5 November by another 21 days.
On Saturday, Museveni
ordered that the lockdown on Mubende and Kassanda be renewed for 21 days, describing the situation as “still fragile”.
“If we open now and a case appears, we will have destroyed all the gains made in this war,” Museveni said in a national address read by his deputy, Jessica Alupo.
“I therefore appeal for calm and understanding. Our health workers will continue to do all it takes to save lives and bring the epidemic to an end.”
According to WHO criteria, an outbreak of the disease ends when there are no new cases for 42 consecutive days -- twice the incubation period of Ebola.
Health Minister Jane Ruth Aceng told AFP this week that the number of new cases being registered was declining, and there were signs Uganda was “winning” the fight.
Uganda’s WHO office said Thursday that as of 22 November, no case had been declared for nine days in Kampala, 10 days in Mubende and 12 days in Kassanda.
Museveni said it was too early to celebrate “but overall I have been briefed that the picture is good”.
The outbreak has claimed 55 lives out of 141 cases, the country’s health ministry said on Friday.
Ebola is spread through bodily fluids. Common symptoms are fever, vomiting, bleeding and diarrhoea.
Outbreaks are difficult to contain, especially in urban environments.
The strain now circulating is known as the Sudan Ebola virus, for which there is no vaccine, although several potential jabs are heading towards clinical trials.